Efficacy and safety of 24 weeks of therapy with bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride compared with enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension : a multicentre, randomised, open study.

Background: The efficacy and safety of therapy with low-dose bendroflumethiazide 1.25 mg/day or 2.5 mg/day and potassium chloride was compared with that of enalapril 10 mg/day and amlodipine 5 mg/day in patients with mild to moderate primary hypertension.

Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women.

Pivmecillinam is a unique beta-lactam antimicrobial that has been used for the treatment of acute uncomplicated urinary infection for > 20 y. Since this agent was introduced, the quinolone antimicrobials have become widely used for the same indication. This study compared the efficacy of a 3-d regimen of pivmecillinam 400 mg b.

Patients' experiences of antihypertensive drugs in routine use: results of a Danish general practice survey.

A questionnaire-based survey of 1843 patients with hypertension was conducted in Denmark to profile patients' experiences of antihypertensive therapy. A high proportion of patients were found to have experienced adverse effects attributable to antihypertensive drug therapy. The pattern of adverse event reporting was consistent with the known pharmacology of the drugs prescribed.